Aquestive Therapeutics Q1 2024 GAAP EPS $(0.17) Misses $(0.07) Estimate, Sales $12.053M Miss $12.262M Estimate
Author: Benzinga Newsdesk | May 07, 2024 05:48pm
Aquestive Therapeutics (NASDAQ:
AQST) reported quarterly losses of $(0.17) per share which missed the analyst consensus estimate of $(0.07) by 142.86 percent. This is a 254.55 percent decrease over earnings of $0.11 per share from the same period last year. The company reported quarterly sales of $12.053 million which missed the analyst consensus estimate of $12.262 million by 1.71 percent. This is a 8.25 percent increase over sales of $11.134 million the same period last year.
Posted In: AQST